Iqvia Government Solutions Inc.

Iqvia Government Solutions Inc., a subsidiary of Iqvia Inc., delivers healthcare data, analytics, and software-as-a-service platforms to federal health agencies as a prime contractor (94% of recent awards) on full-and-open, non-set-aside contracts. The Falls Church, Virginia-based firm competes across a $56.8 billion combined potential-value federal footprint spanning 287 recent prime and sub awards, with no SBA designations and no recurrence of set-aside competition across its portfolio.

Iqvia Government Solutions operates as a provider of longitudinal pharmaceutical prescription data, drug utilization surveillance systems, healthcare analytics platforms, and clinical research software supporting post-market drug safety, regulatory decision-making, and public health epidemiology. Representative prime work includes a $24.4 million CDC Pittsburgh definitive contract for IQVIA Pharmacy Data (firm fixed price, awarded September 2024 with ultimate completion September 2027); an $11.97 million CDC Pittsburgh definitive contract for the IQVIA Health Data Engine (September 2024–September 2028); a $34.06 million Centers for Medicare and Medicaid Services sole-source delivery order under GSA Multiple Award Schedule for prescription drug data and information purchases (January 2025–January 2030, time and materials); and an $11.1 million Drug Enforcement Administration definitive contract for pharmaceutical prescription data collection (August 2025–July 2030). The vendor also holds a $16.8 million FDA Indefinite Delivery Contract for outpatient longitudinal drug utilization data (August 2025–August 2027) and a $75 million FDA CBER BEST Initiative 3 multiple-award IDC for biologics effectiveness and safety surveillance data (awarded September 2024, ceiling through September 2029).

Customer concentration sits heavily with the Department of Health and Human Services ecosystem. The FDA dominates both award count and dollar value—67 awards with $542.3 million combined potential value—followed by CDC Pittsburgh (37 awards, $99.8 million), CMS (13 awards, $136.4 million), and the Office of the Assistant Secretary for Administration (12 awards, $519.1 million). By potential value, the Defense Health Agency ranks first at $35.03 billion combined potential value across 11 awards, anchored by large IDV ceilings; the FDA ranks second at $542.3 million, CDC Pittsburgh third, and CMS fourth. Across the top five customers by potential value, Iqvia captures 64% of its combined potential-value footprint. The vendor serves 50 distinct federal agencies in total, including NASA, the National Institutes of Health, the Department of Defense, and the Department of the Army, indicating breadth beyond health agencies.

Iqvia holds positions on five principal parent vehicles: the Chief Information Officer Commodities and Solutions GWAC (32 task orders, $40.9 million combined potential value), Federal Supply Schedule GS35F0763M (19 task orders, $53.3 million), Indefinite Delivery Contract FA701406A3001 (14 task orders, $21.6 million), Federal Supply Schedule GS35F0083T (7 task orders, $11.2 million), and Indefinite Delivery Contract HHSF223200810021I (8 task orders, $3 million). These vehicles span multiple acquisition channels—GSA Schedules, GSA GWACs, and agency-specific IDCs—positioning the vendor to respond to task orders across civilian health and defense agencies.

Activity has plateaued in recent years after steady growth through 2024. Awards per year ran 13 in 2022, 15 in 2023, and 16 in 2024, then dropped to 7 in 2025 and 6 in 2026, reflecting portfolio consolidation or a shift toward larger task orders within existing IDVs rather than new prime awards. Thirteen awards with combined potential value $79.6 million face ultimate completion within the next twenty-four months and represent recompete exposure for Iqvia and opportunity for competitors on renewal cycles.

Service Contract Inventory captures $98 million in invoiced federal service-contract revenue across fiscal years 2022–2025 (prime contracts only), a strict subset of the vendor's total federal revenue. Invoicing ran $23.1 million in FY2022, $21.6 million in FY2023, $25.6 million in FY2024, and $27.7 million in FY2025, showing flat-to-modest growth. The SCI dataset reports federal FTE delivery of 20.9 FTEs in FY2022, 5.0 FTEs in FY2023, 10.8 FTEs in FY2024, and 14.8 FTEs in FY2025, indicating high volatility in contract-reported labor allocations year to year—typical of data-licensing and software-subscription contracts where work is front-loaded or episodic. Government-paid hourly rates on federal services contracts span a wide spectrum: 10th percentile $312.66 per hour, median $3,874.29 per hour, 90th percentile $24,426.17 per hour, reflecting a portfolio mix of junior analyst work on data processing alongside senior pharmakokinetics, epidemiology, and program-management labor.

Iqvia operates predominantly as a prime contractor (94% of awards) and primarily self-performs delivery across its contracts. Across SCI-reportable prime contracts, subcontractors account for an average 4% of total contractor hours, with 11 named subcontractors reported in the SCI dataset. On the sub side, Iqvia subcontracts to primes including Dynport Vaccine Company LLC (Phase 1 services), Takeda Vaccines Inc. (flavivirus and zika testing work), Vista Defense Technologies LLC (observational medical outcomes partnership data science support), Management Sciences For Health Inc. (USAID Medicines, Technologies, and Pharmaceutical Services Program), and Hendall Inc. (program evaluation work), indicating a minor but active sub footprint in vaccine development, international health, and data science support.

The vendor holds no federal grant awards as prime recipient in the source, but appears as a sub-recipient on two Tennessee Department of Health sub-grants (awarded February 2023 and July 2023). The parent company, Iqvia Inc., operates a substantially larger global healthcare data and life-sciences research business; the Government Solutions subsidiary serves as the federal contracting entity for U.S. government work.